Angiodynamics Inc. (ANGO) Insider Trading

Last 12 months

Insiders sold $344k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. SVP Quality and Regulatory Warren Nighan Jr sold $344k on Jul 30, 27% of their stake, outside a plan. The last open-market buy by an executive or director was in Oct 2025.

Net open-market

−$344k

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Oct 2025

Oct 21, 2025

Get an email when ANGO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jul 30	Warren Nighan Jr SVP Quality and Regulatory	SoldNo plan	23,370	$14.72	$344k	27%	Form 4
Oct 21, 2025	Lawrence T Weiss SVP, Chief Legal Officer	Bought	10,000	$11.81	$118k	12%	Form 4
Oct 13, 2025	Stephen A Trowbridge EVP and CFO	Bought	890	$11.16	$10k	0.3%	Form 4
Oct 9, 2025	James C Clemmer President and CEO	Bought	10,000	$11.15	$112k	1.1%	Form 4
Jan 16, 2025	Warren Nighan Jr SVP Quality and Regulatory	SoldNo plan	4,060	$12.31	$50k	8.8%	Form 4

Jul 30No plan
Warren Nighan Jr
SVP Quality and Regulatory · sold 23,370 at $14.72
$344k
27% of stake
Oct 21, 2025
Lawrence T Weiss
SVP, Chief Legal Officer · bought 10,000 at $11.81
$118k
12% of stake
Oct 13, 2025
Stephen A Trowbridge
EVP and CFO · bought 890 at $11.16
$10k
0.3% of stake
Oct 9, 2025
James C Clemmer
President and CEO · bought 10,000 at $11.15
$112k
1.1% of stake
Jan 16, 2025No plan
Warren Nighan Jr
SVP Quality and Regulatory · sold 4,060 at $12.31
$50k
8.8% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ANGO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

PRCTProcept BioRobotics Corporation

TCMDTactile Systems Technology Inc.

MDXGMiMedx Group, Inc.

SKINSkinHealth Systems Inc.

LMATLemaitre Vascular Inc.

KIDSOrthoPediatrics Corp.

ARAYAccuray Incorporated

CERSCerus Corporation

Spot a number that looks wrong? Check it in ANGO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ANGO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.